Biotech

All Articles

Turnstone lays off 60%, shocks C-suite to stretch out cash money

.Turnstone Biologics is actually reducing its own head count through 60% and agitating its C-suite i...

Gilead quits on $15M MASH bet after weighing preclinical information

.In a year that has seen an approval and a plethora of readouts for metabolic dysfunction-associated...

Texas biotech axes cancer contract, pins wishes on excessive weight

.Alaunos Therapies is axing an arrangement with Precigen, losing hope licensing legal rights to a ta...

Capricor allotments more records for DMD therapy after starting BLA

.Capricor Rehabs is actually taking a success lap for their stage 2 Duchenne muscle dystrophy (DMD) ...

FDA spots Kezar lupus test in hold complying with 4 client fatalities

.The FDA has positioned Kezar Lifestyle Sciences' lupus trial on grip after the biotech flagged 4 de...

Phase 3 Scholar Rock test attacks SMA objective, delivering stock up 200%

.A period 3 trial of Historian Rock's spinal muscular degeneration (SMA) applicant has actually hit ...

CAMP 4 is actually latest to eye IPO, while Upstream define $182M program

.RNA biotech CAMP4 Therapies has actually defined plans for a $67 million IPO, along with inflammati...

Galecto buys leukemia medication, loses bone cancer asset in pivot

.A year after the failure of an idiopathic pulmonary fibrosis candidate delivered Galecto on a seek ...

Judo throws down $100M to knock senseless renal disease

.Taking the floor covering is Judo Biography, an up-and-coming biotech armed along with $one hundred...

AstraZeneca spends CSPC $100M for preclinical heart disease drug

.AstraZeneca has paid CSPC Pharmaceutical Team $100 million for a preclinical heart attack medicatio...